Loss per Share

Loss per share were computed as follows (in millions, except share data):



	Three Months Ended						Nine Months Ended
	October 1, 2016			October 3, 2015			October 1, 2016			October 3, 2015
Weighted average shares:
Basic weighted average shares outstanding	51,690,204			51,151,541			51,499,447			50,925,976
Effect of dilutive securities outstanding	—			—			—			—
Diluted weighted average and equivalent shares outstanding	51,690,204			51,151,541			51,499,447			50,925,976
Net loss	$	(83	)	$	(29	)	$	(154	)	$	(131	)
Basic per share amounts:
Basic weighted average shares outstanding	51,690,204			51,151,541			51,499,447			50,925,976
Per share amount	$	(1.61	)	$	(0.57	)	$	(2.99	)	$	(2.56	)
Diluted per share amounts:
Diluted weighted average shares outstanding	51,690,204			51,151,541			51,499,447			50,925,976
Per share amount	$	(1.61	)	$	(0.57	)	$	(2.99	)	$	(2.56	)

Anti-dilutive securities consist primarily of stock appreciation rights (SARs) with an exercise price greater than the average market closing price of the Class A common stock.

Due to net losses in both the third quarter and first nine months of 2016 and 2015, options, awards and warrants were anti-dilutive and therefore excluded from the earnings per share calculation. These excluded outstanding options, awards and warrants are as follows:



	Three Months Ended		Nine Months Ended
	October 1, 2016	October 3, 2015	October 1, 2016	October 3, 2015
Potentially dilutive shares	1,340,123	1,435,155	1,366,130	1,492,882